Information Provided By:
Fly News Breaks for February 22, 2017
MDT
Feb 22, 2017 | 08:59 EDT
Needham analyst Mike Matson raised his price target for Medtronic to $91 from $84 after Q3 revenue and EPS beat consensus and the company maintained its 2017 guidance. The analyst believes the shares remain at a discount to peers and reiterates a Buy rating on the stock.